SHARK

Clinical trials for SHARK explained in plain language.

Never miss a new study

Get alerted when new SHARK trials appear

Sign up with your email to follow new studies for SHARK, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New hope for Tough-to-Treat kidney cancer? early trial tests novel drug combo

Disease control Not yet recruiting

This early-stage study aims to see if a new drug called HC-7366, when combined with standard immunotherapy drugs (nivolumab with or without ipilimumab), can help control advanced clear cell kidney cancer. It will enroll about 35 adults to test the safety of these combinations and…

Matched conditions: SHARK

Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

Last updated Mar 23, 2026 15:16 UTC

SHARK

Get alerted when new SHARK trials appear

New hope for Tough-to-Treat kidney cancer? early trial tests novel drug combo